Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

44.3K
Overview
44.3K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.4K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K
Vaccine Production01:23

Vaccine Production

152
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
152
Vaccines01:21

Vaccines

104
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
104

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The strategic importance of mRNA vaccine technologies in Africa for achieving public health independence.

Communications medicine·2026
Same author

Lipid Nanoparticle-Encapsulated TALEN-Encoding mRNA Inactivates Hepatitis B Virus Replication in Cultured Cells and Transgenic Mice.

Viruses·2025
Same author

In Vitro Transcribed Artificial Primary MicroRNA for the Inhibition of Hepatitis B Virus Gene Expression in Cultured Cells.

Microorganisms·2025
Same author

Bridging gene therapy and next-generation vaccine technologies.

Gene therapy·2024
Same author

AAV Immunotoxicity: Implications in Anti-HBV Gene Therapy.

Microorganisms·2023
Same author

Production, Characterization, and Assessment of Permanently Cationic and Ionizable Lipid Nanoparticles for Use in the Delivery of Self-Amplifying RNA Vaccines.

Pharmaceutics·2023

Related Experiment Video

Updated: May 6, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.4K

Recent Advances in Designing Adeno-Associated Virus-Based Vaccines Against Viral Infections.

Njabulo Mnyandu1, Ridhwaanah Jacobs1, Patrick Arbuthnot1

  • 1Wits/SAMRC Antiviral Gene Therapy Research Unit, Infectious Diseases and Oncology Research Institute (IDORI), Faculty of Health Sciences, University of the Witwatersrand, Parktown 2193, South Africa.

Pharmaceutics
|November 27, 2024
PubMed
Summary

Adeno-associated viral vectors show promise for developing new anti-viral vaccines. This review explores their recent advancements and potential as a vaccine platform.

Keywords:
SARS-CoV-2adeno-associated viral vectorsvaccinesviral infections

More Related Videos

Author Spotlight: Improved Method for Production and Purification of Adeno-Associated Viral Vectors
09:12

Author Spotlight: Improved Method for Production and Purification of Adeno-Associated Viral Vectors

Published on: April 5, 2024

2.8K
Author Spotlight: Advancing Gene Therapy Research with High-Titer Adeno-Associated Virus Vector Production
05:51

Author Spotlight: Advancing Gene Therapy Research with High-Titer Adeno-Associated Virus Vector Production

Published on: May 3, 2024

1.4K

Related Experiment Videos

Last Updated: May 6, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.4K
Author Spotlight: Improved Method for Production and Purification of Adeno-Associated Viral Vectors
09:12

Author Spotlight: Improved Method for Production and Purification of Adeno-Associated Viral Vectors

Published on: April 5, 2024

2.8K
Author Spotlight: Advancing Gene Therapy Research with High-Titer Adeno-Associated Virus Vector Production
05:51

Author Spotlight: Advancing Gene Therapy Research with High-Titer Adeno-Associated Virus Vector Production

Published on: May 3, 2024

1.4K

Area of Science:

  • Virology
  • Immunology
  • Vaccinology

Background:

  • Viral infections cause over 80% of deadly pandemics globally.
  • Vaccination is the primary strategy for preventing viral disease spread.
  • Next-generation vaccines include mRNA and viral vector technologies.

Purpose of the Study:

  • To review recent developments in adeno-associated viral vector technology.
  • To assess the potential of adeno-associated viral vectors as anti-viral vaccines.

Main Methods:

  • Review of current scientific literature on viral vector vaccines.
  • Analysis of adeno-associated viral vectors in vaccine development.
  • Comparison with existing vaccine platforms like mRNA and adenoviral vectors.

Main Results:

  • Adenoviral vectors offer sustained antibody responses but have associated adverse events.
  • Adeno-associated viral vectors induce a weaker cellular immune response than adenoviral vectors.
  • Recent research is re-evaluating adeno-associated viral vectors for vaccine applications.

Conclusions:

  • Adeno-associated viral vectors present a potential alternative for anti-viral vaccine development.
  • Further research is needed to overcome limitations and optimize adeno-associated viral vectors for widespread vaccine use.